Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00582_DB01118_nanopub.RAJQNCBH2nDJI7AI5kaIYhufaU79kcio3-17MLUbwmGp4#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00582_DB01118 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00582_DB01118 label "DDI between Voriconazole and Amiodarone - Additive QTc prolongation may occur. Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of amiodarone by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of amiodarone if voriconazole is initiated, discontinued or dose changed. [drugbank_resource:DB00582_DB01118]" assertion.
- drugbank_resource:DB00582_DB01118 identifier "drugbank_resource:DB00582_DB01118" assertion.
- drugbank_resource:DB00582_DB01118 title "DDI between Voriconazole and Amiodarone - Additive QTc prolongation may occur. Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of amiodarone by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of amiodarone if voriconazole is initiated, discontinued or dose changed." assertion.
- drugbank:DB01118 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00582_DB01118 assertion.
- drugbank:DB00582 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00582_DB01118 assertion.